Bell Investment Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.85K Buy
59
+4
+7% +$435 ﹤0.01% 750
2026
Q1
$5.08K Hold
55
﹤0.01% 952
2025
Q4
$5.62K Hold
55
﹤0.01% 927
2025
Q3
$3.44K Hold
55
﹤0.01% 1101
2025
Q2
$2.86K Hold
55
﹤0.01% 1214
2025
Q1
$2.34K Hold
55
﹤0.01% 1247
2024
Q4
$1.68K Hold
55
﹤0.01% 1395
2024
Q3
$1.26K Hold
55
﹤0.01% 1523
2024
Q2
$1.59K Buy
+55
New +$1.28K ﹤0.01% 1452
2023
Q3
Sell
-19
Closed -$681 1960
2023
Q2
$681 Hold
19
﹤0.01% 1701
2023
Q1
$446 Buy
19
+6
+46% +$171 ﹤0.01% 1869
2022
Q4
$354 Sell
13
-14
-52% -$641 ﹤0.01% 1914
2022
Q3
$1K Hold
27
﹤0.01% 1416
2022
Q2
$1K Buy
+27
New +$1.34K ﹤0.01% 1443
2021
Q4
$1K Sell
5
-10
-67% -$1.03K ﹤0.01% 1447
2021
Q3
$2K Buy
+15
New +$1.78K ﹤0.01% 1070

Other funds holding GH

Bell Investment Advisors's GH Position: Q2 2026 in Review

Bell Investment Advisors increased its Guardant Health (GH) stake by 7.3% in Q2 2026, buying an estimated $435 and bringing the position to 59 shares worth $8.85K. The position accounts for ﹤0.01% of the portfolio, ranked #750.

Bell Investment Advisors first reported a position in GH in Q3 2021 and has held it in 16 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Bell Investment Advisors held 59 shares of Guardant Health worth $8.85K as of Q2 2026.
  • Bell Investment Advisors bought 4 Guardant Health shares in Q2 2026, an estimated $435.
  • Guardant Health made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #750 holding.
  • Bell Investment Advisors first reported a position in Guardant Health in Q3 2021 and has held it in 16 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.